Alpha Tau Medical Ltd.
DRTS
$4.03
$0.153.87%
NASDAQ
| 06/30/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | 2.64M | 2.74M | 2.12M | 2.19M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 9.65M | 10.27M | 8.29M | 9.05M | |
| Operating Income | -9.65M | -10.27M | -8.29M | -9.05M | |
| Income Before Tax | -10.05M | -9.47M | -6.92M | -7.37M | |
| Income Tax Expenses | 65.00K | 2.00K | 0.00 | 3.00K | |
| Earnings from Continuing Operations | -10.11M | -9.48M | -6.92M | -7.37M | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -10.11M | -9.48M | -6.92M | -7.37M | |
| EBIT | -9.65M | -10.27M | -8.29M | -9.05M | |
| EBITDA | -9.38M | -10.00M | -8.02M | -8.77M | |
| EPS Basic | -0.13 | -0.14 | -0.10 | -0.11 | |
| Normalized Basic EPS | -0.08 | -0.08 | -- | -0.07 | |
| EPS Diluted | -0.13 | -0.14 | -0.10 | -0.11 | |
| Normalized Diluted EPS | -0.08 | -0.08 | -- | -0.07 | |
| Average Basic Shares Outstanding | 80.45M | 70.14M | 69.99M | 69.87M | |
| Average Diluted Shares Outstanding | 80.45M | 70.14M | 69.99M | 69.87M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |